Jun 13, 2016
8:5
For every 5 shares held, investors received 8. The price per share adjusted from $28.59 to $17.87.
The split itself did not change the total investment value.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (SZSE:002399) operates in the Pharmaceuticals: major industry.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A company overviewShenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A's most recent stock split was on June 13, 2016. It was a 8-for-5 forward split, so shareholders received 8 shares for every 5 they held.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A (SZSE:002399) has split its stock 2 times: a 2-for-1 split on April 29, 2011 and a 8-for-5 split on June 13, 2016.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A has split its stock 2 times. This history records 2 forward splits between April 29, 2011 and June 13, 2016.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A's 8-for-5 split on June 13, 2016, every 5 shares became 8 shares.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on June 13, 2016, 10 years ago. Companies announce splits in advance, and any new SZSE:002399 split will appear on this page.
Already premium?